top of page
Search
Kellie Meade
May 25, 20222 min read
Aalto Bio Reagents Acquired by Biosynth Carbosynth to Strengthen its Global Life Science Enterprise
Urs Spitz (left) – CEO and President, Biosynth Carbosynth and Philip Noone (right) – CEO, Aalto Bio Reagents Dublin, 25 May 2022 - Aalto...
1,228 views0 comments
Kellie Meade
May 11, 20223 min read
Aalto Bio Reagents Launches New Recombinant Mayaro Virus E2 Gylcoprotein, Domain A.
Dublin, Ireland – May 11th 2022 – Aalto Bio Reagents Ltd., a leading global developer of critical raw materials for the development of...
138 views0 comments
Rachel O'Reilly
Apr 4, 20223 min read
Aalto Bio Reagents Announces 15 Pathogen Development Strategy to Solve the World's Future Diseases
Aalto Bio Reagents Ltd., a leading global developer of critical raw materials and reagents for the development of diagnostic tests, today...
274 views0 comments
Rory Quirkie
Feb 2, 20222 min read
Aalto Bio Reagents Announces its New SARS-CoV-1 Spike Protein S1 Domain (Korean Outbreak Strain)
Dublin, Ireland – February 2nd 2022 – Aalto Bio Reagents ltd. a leading developer of critical raw materials and reagents for the...
98 views0 comments
bottom of page